Stanford Medicine News

Precision Health

Read about Stanford Medicine's vision for leading the biomedical revolution.

Donor e-newsletter

This quarterly e-newsletter highlights Stanford Medicine news and events.

Planning for the Future

The latest planned giving newsletter was mailed November 2015.

  • Combination drug therapy shrinks pancreatic tumors in mice

    A combination of two drugs, one already approved by the Food and Drug Administration, appears to be effective at shrinking pancreatic cancers in laboratory mice, according to a new study by researchers at the Stanford University School of Medicine.

  • Stanford launches smartphone app to study heart health

    A free iPhone app allows users to contribute to a study of human heart health while learning about the health of their own hearts, and uses a new software framework developed by Apple.

  • Photovoltaic retinal implant could restore functional sight, researchers say

    A team led by Stanford University researchers has developed a wireless retinal implant that they say could restore vision five times better than existing devices.

  • Precision Health, Predicting and Preventing Disease

    Precision health takes a big-data approach to disease prevention and detection, focusing on the various factors that help maintain health throughout life.

  • Doctor, nurses honored for advances made in early days of cardiac care

    Alfred Spivack taught nurses to do a number of jobs generally restricted to doctors in the early days of Stanford’s coronary care unit, and also helped to developed new technology for cardiac care.

  • Customized DNA rings aid early cancer detection in mice, study finds

    Imagine: You pop a pill into your mouth and swallow it. It dissolves, releasing tiny particles that are absorbed and cause only cancerous cells to secrete a specific protein into your bloodstream. Two days from now, a finger-prick blood sample will expose whether you’ve got cancer and even give a rough idea of its extent.

  • Stanford Medicine’s Academic Advantage

    Leaders from across Stanford Medicine discuss together how Bioinformatics, genomics, and other emerging disciplines promise to transform the very concept of medicine—from treating disease to predicting and preventing it and the common aspiration that exists at Stanford Medicine to improve human health.

  • 'Big data' approach helps pinpoint possible new stent drug to prevent heart attacks

    Stanford Medicine researchers hunting for a better drug coating for coronary stents have pinpointed a cancer drug as a possible candidate. “This could have major clinical impact,” according to Euan Ashley, MD, associate professor of cardiovascular medicine and genetics.

  • Newly identified molecular network in brain implicated in autism, researchers say

    A defect in communication between the two halves of the brain may be responsible for some cases of autism, according to a study by Stanford Medicine researchers in the Department of Genetics.

  • Stanford launches major effort to expedite vaccine discovery with $50 million grant

    Stanford University has received a grant from the Bill & Melinda Gates Foundation to accelerate efforts in vaccine development. The $50 million grant over 10 years will build on existing technology developed at Stanford to establish the Stanford Human Systems Immunology Center.

  • Streamlining cancer care

    Sharron Brockman has become all too familiar with cancer. Diagnosed 18 months ago with stage-3 ovarian cancer, Brockman has gone through two rounds of chemotherapy and had to drop out of a clinical trial because of a reaction to one of the medications. But when she decided to continue her treatment this spring at the Stanford Cancer Center, the Sacramento resident came across something new: her own multidisciplinary care coordinator.

  • Mix and Match: Seeking unexpected treatments in biomedical databases

    Researchers have found a new way to draw on the world’s wealth of biological data: They’re digging through it to find new uses for old drugs—a strategy called drug repositioning.

  • Bioengineer designs diagnostic microscope costing less than $1

    It’s an invention that would make TV’s secret agent MacGyver proud: a fully functional microscope that can be assembled from folded paper and a tiny bead of glass. And it only costs about 50 cents.

  • Stanford/Packard scientists find new uses for existing drugs by mining gene-activity data banks

    Researchers at the Stanford University School of Medicine have paired up medicines and maladies with help from a molecular “” When the scientists applied an “opposites attract” algorithm to publicly available databases, surprising sparks flew: They found potential compatibilities between numerous existing drugs and diseases for which those drugs had never before been thought to be beneficial.

  • On shaky ground: Building to withstand a major earthquake

    The new Stanford Hospital is being constructed to withstand the most severe tremors. When completed, in 2017, the building will be one of the most seismically safe hospitals in the country, able to continue operations after an 8.0, or “great,” earthquake.

  • Stanford's big data conference: How 1s and 0s are advancing medicine

    Massive, ongoing advances in computational processing power and interconnectedness are already changing the way medical research is done. But even more-disruptive outcomes—including changes in the very practice of medicine at the day-to-day clinical level—lie just ahead.

  • Stanford team makes switching off cells with light as easy as switching them on

    In 2005, a Stanford University scientist discovered how to switch brain cells on or off with light pulses by using special proteins from microbes to pass electrical current into neurons.

  • Blood test could provide rapid, accurate method of detecting solid cancers, study finds

    A blood sample could one day be enough to diagnose many types of solid cancers, or to monitor the amount of cancer in a patient’s body and responses to treatment. Previous versions of the approach, which relies on monitoring levels of tumor DNA circulating in the blood, have required cumbersome and time-consuming steps to customize it to each patient or have not been sufficiently sensitive.

  • New Clinical Genomics Program Blends Stanford’s Capabilities and Expertise to Advance Patient Care

    A new pilot program in clinical genomics will allow a small group of patients at Stanford Hospital & Clinics and Lucile Packard Children’s Hospital Stanford to have their DNA deciphered to help doctors with diagnosis and treatment.

  • Michael Levitt wins Nobel Prize in Chemistry

    Michael Levitt, PhD, professor of structural biology at the Stanford University School of Medicine, has won the 2013 Nobel Prize in Chemistry.